FOLD Q4 2017 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+420.3% YoY

Gross Profit

$12M82.3% margin

Operating Income

-$68M-459.5% margin

Net Income

-$69M-469.9% margin

EPS (Diluted)

$-0.43

QoQ Revenue Growth

+35.5%

Cash Flow

Operating Cash Flow

-$74M

Free Cash Flow

-$75M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$627M

Total Liabilities

$274M

Stockholders' Equity

$353M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$3M	+420.3%
Gross Profit	$12M	$2M	+417.5%
Operating Income	-$68M	-$45M	-49.0%
Net Income	-$69M	-$59M	-18.0%